Douglas A. Tremblay, MD, discusses the long-term data supporting ropeginterferon alfa-2b-njft as treatment in patients with polycythemia vera.

Learn more about whether Alvotech or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades ...

I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer ...

Screening for cancers should only be done in healthy people whose life expectancy is long enough that the benefit of getting ...

Cell-free DNA testing uses a small amount of a person's blood and tests it for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory before ...

I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer ...

I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? — M.N.

Dear Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...

Incyte’s The Unseen Journey illustrates the hidden emotional and physical toll of myeloproliferative neoplasms (MPNs), a ...

A panelist discusses how available therapeutic strategies have enhanced their approach to treatment sequencing in patients ...